Current Status and Future Perspectives of Immunotherapies in Bladder Cancer
Bladder cancer exhibits a broad spectrum of progression, ranging from early stage to metastatic disease. Approximately 75% of newly diagnosed patients present with non-muscle-invasive bladder cancer, while the remaining 25% have muscle-invasive bladder cancer or metastatic disease. The prognosis of...
Saved in:
| Main Authors: | Gökhan Çolak, Bilgin Demir |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2025-08-01
|
| Series: | Acta Haematologica Oncologica Turcica |
| Subjects: | |
| Online Access: | https://www.actaoncologicaturcica.com/articles/current-status-and-future-perspectives-of-immunotherapies-in-bladder-cancer/doi/ahot.galenos.2025.2025-3-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements in bladder cancer immunotherapy: a focus on intravesical approaches
by: Xia Tang, et al.
Published: (2025-07-01) -
Exploring the Immunoresponse in Bladder Cancer Immunotherapy
by: Inmaculada Ruiz-Lorente, et al.
Published: (2024-11-01) -
Loss of OBSCN expression promotes bladder cancer progression but enhances the efficacy of PD-L1 inhibitors
by: Tao Wang, et al.
Published: (2025-03-01) -
Advances in the immunological microenvironment and immunotherapy of bladder cancer
by: Le Meng, et al.
Published: (2025-08-01) -
Predictive biomarkers in the era of immunotherapy for gastric cancer: current achievements and future perspectives
by: Fujing Sun, et al.
Published: (2025-05-01)